Form4insider filings, from the source

SEC Form 4 · accession 0001171843-26-005844

Edesa Biotech, Inc. · EDSA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Pardeep Nijhawan
Officer — Chief Executive Officer · Director · 10% Owner
Period of report
Sep 1, 2026
Accepted (ET)
Sep 1, 2026 · 6:12 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001540159

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common SharesF1Sep 1, 2026A5,714$0.00A899,100D
Common SharesF2holding———402,702IHeld by Pardeep Nijhawan Medicine Professional Corporation
Common SharesF3holding———32,609IHeld by The New Nijhawan Family Trust 2015
Common SharesF2holding———32,013IHeld by The Digestive Health Clinic Inc.
Common SharesF2holding———53,104IHeld by 1968160Ontario Inc.

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses